SCHEMBL18190832

SCHEMBL18190832

O=C(O)N(Cc1ccccc1)C1(C(F)(F)F)CC1

nearest known ligand 0.45

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CNR2 P34972 1/20 0.45
CYP2C19 P33261 1/20 0.41
CES1 P23141 1/20 0.41
NPSR1 Q6W5P4 1/20 0.39
NPC1 O15118 2/20 0.39
RAB9A P51151 2/20 0.39
CA12 O43570 1/20 0.39
CA9 Q16790 1/20 0.39
TDP1 Q9NUW8 1/20 0.38
MEN1 O00255 1/20 0.38
KMT2A Q03164 1/20 0.38
KDM4E B2RXH2 1/20 0.38
HDAC3 O15379 1/20 0.38
HDAC4 P56524 1/20 0.38
HDAC1 Q13547 1/20 0.38
HDAC6 Q9UBN7 1/20 0.38
MTOR P42345 1/20 0.38
MLYCD O95822 1/20 0.38
LMNA P02545 1/20 0.38
RIPK1 Q13546 2/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL18154267 0.74 ALDH1A1 (0.40) CNR2TDP1MEN1KMT2ALMNA
SCHEMBL1509098 0.72 NPC1 (0.41) NPSR1NPC1RAB9ACA12CA9
SCHEMBL1509096 0.71 NPC1 (0.40) NPSR1NPC1RAB9ACA12CA9
SCHEMBL2833020 0.70 MEN1 (0.36) CNR2NPSR1NPC1RAB9ACA12
SCHEMBL23803539 0.69 RIPK1 (0.43) CYP2C19CES1NPSR1RIPK1
SCHEMBL23819831 0.69 RIPK1 (0.43) CYP2C19CES1NPSR1NPC1RAB9A
Hydrochloric Acid SCHEMBL16194970 0.69 SRR (0.42) CYP2C19NPSR1NPC1RAB9ACA12
SCHEMBL16728439 0.69 NPSR1 (0.44) CNR2NPSR1NPC1RAB9ACA12
SCHEMBL16728415 0.69 NPSR1 (0.44) CNR2NPSR1NPC1RAB9ACA12
SCHEMBL1933707 0.69 NPSR1 (0.38) CNR2NPSR1NPC1RAB9ACA12

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3265448-A1 RILUZOLE PRODRUGS AND THEIR USE Biohaven Pharmaceutical Holding Company Ltd. (US) 2018-01-10 EP disclosed
WO-2016140879-A9 RILUZOLE PRODRUGS AND THEIR USE BIOHAVEN PHARMACEUTICAL HOLDING COMPANY LTD. (US) 2016-11-03 WO disclosed